JP2021532114A5 - - Google Patents
Info
- Publication number
- JP2021532114A5 JP2021532114A5 JP2021503581A JP2021503581A JP2021532114A5 JP 2021532114 A5 JP2021532114 A5 JP 2021532114A5 JP 2021503581 A JP2021503581 A JP 2021503581A JP 2021503581 A JP2021503581 A JP 2021503581A JP 2021532114 A5 JP2021532114 A5 JP 2021532114A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- age
- antibody
- modified
- antibodies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702229P | 2018-07-23 | 2018-07-23 | |
| US62/702,229 | 2018-07-23 | ||
| PCT/US2019/043071 WO2020023532A1 (en) | 2018-07-23 | 2019-07-23 | Methods and compositions for treating chronic effects of radiation and chemical exposure |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021532114A JP2021532114A (ja) | 2021-11-25 |
| JP2021532114A5 true JP2021532114A5 (cg-RX-API-DMAC7.html) | 2023-05-26 |
Family
ID=67777383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503581A Pending JP2021532114A (ja) | 2018-07-23 | 2019-07-23 | 放射線曝露及び化学物質曝露の慢性影響を治療するための方法及び組成物 |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20220175916A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3826670A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2021532114A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020023532A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102037119B (zh) | 2008-05-23 | 2015-06-24 | Siwa有限公司 | 促进再生的方法、组合物及设备 |
| US8721571B2 (en) | 2010-11-22 | 2014-05-13 | Siwa Corporation | Selective removal of cells having accumulated agents |
| AU2015318036B2 (en) | 2014-09-19 | 2021-07-01 | Siwa Corporation | Anti-AGE antibodies for treating inflammation and auto-immune disorders |
| US10358502B2 (en) | 2014-12-18 | 2019-07-23 | Siwa Corporation | Product and method for treating sarcopenia |
| US9993535B2 (en) | 2014-12-18 | 2018-06-12 | Siwa Corporation | Method and composition for treating sarcopenia |
| IL283726B2 (en) | 2016-02-19 | 2025-05-01 | Siwa Corp | A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer |
| EP3443007A1 (en) | 2016-04-15 | 2019-02-20 | Siwa Corporation | Anti-age antibodies for treating neurodegenerative disorders |
| US11213585B2 (en) | 2016-06-23 | 2022-01-04 | Siwa Corporation | Vaccines for use in treating various diseases and disorders |
| US10961321B1 (en) | 2017-01-06 | 2021-03-30 | Siwa Corporation | Methods and compositions for treating pain associated with inflammation |
| US10995151B1 (en) | 2017-01-06 | 2021-05-04 | Siwa Corporation | Methods and compositions for treating disease-related cachexia |
| US10858449B1 (en) | 2017-01-06 | 2020-12-08 | Siwa Corporation | Methods and compositions for treating osteoarthritis |
| US10925937B1 (en) | 2017-01-06 | 2021-02-23 | Siwa Corporation | Vaccines for use in treating juvenile disorders associated with inflammation |
| BR112019021471A2 (pt) | 2017-04-13 | 2020-05-12 | Siwa Corporation | Anticorpo monoclonal humanizado de produto final da glicação avançada |
| US11518801B1 (en) | 2017-12-22 | 2022-12-06 | Siwa Corporation | Methods and compositions for treating diabetes and diabetic complications |
| US20230181730A1 (en) * | 2020-05-01 | 2023-06-15 | Siwa Corporation | Methods of treating infections |
| WO2022093195A1 (en) * | 2020-10-27 | 2022-05-05 | Siwa Corporation | Methods and compositions for treating osteoarthritis using anti-age antibodies or age antigens |
| WO2022125776A2 (en) * | 2020-12-09 | 2022-06-16 | Siwa Corporation | Methods and compositions for treating kidney diseases |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4217344A (en) | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US5624804A (en) | 1991-12-20 | 1997-04-29 | The Rockefeller University | Immunochemical detection of In vivo advanced glycosylation end products |
| US6387373B1 (en) | 1993-01-15 | 2002-05-14 | Novavax, Inc. | Vaccines containing paucilsmellar lipid vesicles as immunological adjuvants |
| US6380165B1 (en) | 1997-09-19 | 2002-04-30 | The Picower Institute For Medical Research | Immunological advanced glycation endproduct crosslink |
| EP1988918A4 (en) | 2006-02-22 | 2010-04-28 | Novavax Inc | ADJUVANZ AND VACCINE COMPOSITIONS |
| CN102037119B (zh) * | 2008-05-23 | 2015-06-24 | Siwa有限公司 | 促进再生的方法、组合物及设备 |
| WO2012047629A2 (en) * | 2010-09-27 | 2012-04-12 | Siwa Corporation | Selective removal of age-modified cells for treatment of ather0sclerosis |
| CA2859385A1 (en) * | 2011-12-13 | 2013-06-20 | Buck Institute For Research On Aging | Methods for improving medical therapies |
| AU2015318036B2 (en) * | 2014-09-19 | 2021-07-01 | Siwa Corporation | Anti-AGE antibodies for treating inflammation and auto-immune disorders |
| BR112018007422A2 (pt) * | 2015-10-13 | 2018-10-30 | Siwa Corp | anticorpos anti-age e métodos de uso dos mesmos |
| IL283726B2 (en) * | 2016-02-19 | 2025-05-01 | Siwa Corp | A preparation containing an antibody to advanced glycation end products (AGE) for use in the treatment of breast cancer |
| US11213585B2 (en) * | 2016-06-23 | 2022-01-04 | Siwa Corporation | Vaccines for use in treating various diseases and disorders |
| BR112019021471A2 (pt) * | 2017-04-13 | 2020-05-12 | Siwa Corporation | Anticorpo monoclonal humanizado de produto final da glicação avançada |
| EP3619540A1 (en) * | 2017-05-04 | 2020-03-11 | Siwa Corporation | Diagnostic advanced glycation end-product antibodies |
-
2019
- 2019-07-23 EP EP19759765.1A patent/EP3826670A1/en not_active Withdrawn
- 2019-07-23 WO PCT/US2019/043071 patent/WO2020023532A1/en not_active Ceased
- 2019-07-23 JP JP2021503581A patent/JP2021532114A/ja active Pending
- 2019-07-23 US US17/262,684 patent/US20220175916A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021534144A5 (cg-RX-API-DMAC7.html) | ||
| JP2016519932A5 (cg-RX-API-DMAC7.html) | ||
| Deshpande | Enzyme immunoassays: from concept to product development | |
| Brand et al. | Secretory carrier membrane proteins 31-35 define a common protein composition among secretory carrier membranes. | |
| BRPI0507433B8 (pt) | anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit | |
| JP2019522490A5 (cg-RX-API-DMAC7.html) | ||
| Sheng et al. | Separation of antigens and antibodies by immunoaffinity chromatography | |
| WO2018057735A8 (en) | Antibodies for siglec-15 and methods of use thereof | |
| NZ701444A (en) | Antibodies to matrix metalloproteinase 9 | |
| NZ623541A (en) | Human cgrp receptor binding proteins | |
| Tillib et al. | Single-domain antibody-based ligands for immunoaffinity separation of recombinant human lactoferrin from the goat lactoferrin of transgenic goat milk | |
| Reese et al. | Purification of animal immunoglobulin G (IgG) using peptoid affinity ligands | |
| Jones et al. | Isolation of immune complexes and characterisation of their constituent antigens and antibodies in some human diseases: a review | |
| MX2024002150A (es) | Anticuerpos y proteinas de fusion de igg con una semivida prolongada. | |
| CN108139398A (zh) | 颗粒的蛋白质固定方法 | |
| EA201100741A1 (ru) | Антитела к модифицированным пептидам ифр-1/е человека | |
| Łupicka-Słowik et al. | Development of adenosine deaminase-specific IgY antibodies: Diagnostic and inhibitory application | |
| JPS60155133A (ja) | アンチ−イデイオタイプのモノクロナル抗体を採用したアンチ−イデイオタイプワクチン | |
| Yu et al. | An in vivo half-life extended prolactin receptor antagonist can prevent STAT5 phosphorylation | |
| Abdel-Rahman et al. | Preparation of goat and rabbit anti-camel immunoglobulin G whole molecule labeled with horseradish peroxidase | |
| WO2023196658A3 (en) | Antibody compositions and optimization methods | |
| Reese et al. | Novel peptoid-based adsorbents for purifying IgM and IgG from polyclonal and recombinant sources | |
| Holbrook et al. | OX133, a monoclonal antibody recognizing protein-bound N-ethylmaleimide for the identification of reduced disulfide bonds in proteins | |
| Nakazawa et al. | Production and purification of polyclonal antibodies | |
| Yu et al. | Method for studying immunoglobulin G binding on hydrophobic surfaces |